Shiv Kumar Sarin
Institute of Liver & Biliary Sciences · Institute of Liver and Biliary Sciences, India · Institute of Liver & Biliary Sciences (ILBS).
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Shiv Kumar Sarin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:58 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07131306 · National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem Cell Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patient- Phase-II TrialInstitute of Liver and Biliary Sciences, India · not yet recruiting · Acute-On-Chronic Liver Failure · principal investigator
- N/ANCT07131280 · National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Single vs Repeated Cycle of Granulocyte Colony-Stimulating Factor (GCSF) & Darbepoetin in Early Decompensated CirrhosisInstitute of Liver and Biliary Sciences, India · not yet recruiting · Decompensated Cirrhosis · principal investigator
- Ph1NCT07131540 · National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF)Institute of Liver and Biliary Sciences, India · not yet recruiting · Acute-On-Chronic Liver Failure · principal investigator
- Ph3NCT07075315 · National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III TrialInstitute of Liver and Biliary Sciences, India · not yet recruiting · Acute-On-Chronic Liver Failure · principal investigator
- N/ANCT05104541 · Impact of Weight Loss in Cirrhosis With Obesity and MAFLDInstitute of Liver and Biliary Sciences, India · unknown · Liver Cirrhosis, Obesity · principal investigator
- N/ANCT04352491 · An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver DiseaseInstitute of Liver and Biliary Sciences, India · completed · COVID 19 · study director
- N/ANCT04089878 · "To Study the Impact of Balloon-occluded Retrograde Transvenous Obliteration (BRTO)/Plug Assisted Retrograde Transvenous Obliteration (PARTO) Mediated Portal Flow Modulation in Reduction of Ammonia and Improvement in Organ Volume and Functionality in Patients of Cirrhosis With LR ShuntInstitute of Liver and Biliary Sciences, India · unknown · Liver Cirrhoses · principal investigator
- N/ANCT03753438 · Intragastric Balloon in Compensated NASH(Non Alcoholic Steato Hepatitis) CirrhoticsInstitute of Liver and Biliary Sciences, India · completed · Liver Cirrhosis · principal investigator
- N/ANCT01732224 · To Compare the Efficacy of Combined Tenofovir Plus Telbivudine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis BInstitute of Liver and Biliary Sciences, India · completed · Spontaneous Reactivation of Hepatitis B · principal investigator
- Ph3NCT01384578 · Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic SteatohepatitisInstitute of Liver and Biliary Sciences, India · withdrawn · Non Alcoholic Steatohepatitis · study director
- Ph3NCT01384565 · G-CSF and Erythropoetin in Survival of Patients With Decompensated Liver DiseaseInstitute of Liver and Biliary Sciences, India · completed · Chronic Liver Disease · study director
- Ph3NCT01383460 · Efficacy of Granulocyte Colony-stimulating Factor and Erythropoetin for Patients With Acute-on-chronic Liver FailureInstitute of Liver and Biliary Sciences, India · completed · Acute on Chronic Hepatic Failure · study director
- N/ANCT01196481 · Carvedilol + VSL#3 Versus Endoscopic Variceal Ligation for Primary Prophylaxis of Esophageal Variceal Bleeding in Cirrhotic Patients Non Responder to Carvedilol.Institute of Liver and Biliary Sciences, India · completed · Cirrhosis · principal investigator
- N/ANCT01196507 · Early Primary Prophylaxis of Esophageal VaricesInstitute of Liver and Biliary Sciences, India · completed · Cirrhosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:58 UTC. The ranking covers the 200 most relevant of 123 PubMed records, and a shared surname and initials can bring in a namesake. All 123 on PubMed
- Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure.Gastroenterology · 2012323 citationsRCR 9.5
- Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding.N Engl J Med · 1999266 citationsRCR 9.4
- A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.Am J Gastroenterol · 2013244 citationsRCR 8.8
- A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices.Am J Gastroenterol · 2002229 citationsRCR 7.8
- Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.Gastroenterology · 2009225 citationsRCR 6.9
- Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.Hepatology · 2011215 citationsRCR 6.6
- Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial.J Gastroenterol Hepatol · 2003207 citationsRCR 5.8
- An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.Am J Gastroenterol · 2008205 citationsRCR 5.9
- 183 citationsRCR 7.8
- Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study.Hepatology · 2011175 citationsRCR 5.2